These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 29752993)

  • 1. Cancer stem cells: Regulation programs, immunological properties and immunotherapy.
    Zhang D; Tang DG; Rycaj K
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):94-106. PubMed ID: 29752993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches.
    Pan Q; Li Q; Liu S; Ning N; Zhang X; Xu Y; Chang AE; Wicha MS
    Stem Cells; 2015 Jul; 33(7):2085-92. PubMed ID: 25873269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy.
    Luna JI; Grossenbacher SK; Murphy WJ; Canter RJ
    Expert Opin Biol Ther; 2017 Mar; 17(3):313-324. PubMed ID: 27960589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic Targeting of Cancer Stem Cells.
    Zhang J; Li Q; Chang AE
    Surg Oncol Clin N Am; 2019 Jul; 28(3):431-445. PubMed ID: 31079798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source.
    Ruiu R; Tarone L; Rolih V; Barutello G; Bolli E; Riccardo F; Cavallo F; Conti L
    Prog Mol Biol Transl Sci; 2019; 164():119-188. PubMed ID: 31383404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy: Newer Therapeutic Armamentarium against Cancer Stem Cells.
    Singh SP; Singh R; Gupta OP; Gupta S; Brahma Bhatt ML
    J Oncol; 2020; 2020():3963561. PubMed ID: 32211043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Identification of cancer-stem cell antigens and development of CTL-mediated cancer immunotherapy].
    Miyamoto S; Kanaseki T; Hirohashi Y; Tsukahara T; Kikuchi Y; Sato N; Torigoe T
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):40-47. PubMed ID: 28539553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.
    Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C
    Cells; 2020 Aug; 9(8):. PubMed ID: 32823711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells.
    Hirohashi Y; Torigoe T; Inoda S; Takahashi A; Morita R; Nishizawa S; Tamura Y; Suzuki H; Toyota M; Sato N
    Immunotherapy; 2010 Mar; 2(2):201-11. PubMed ID: 20635928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Approach for Cancer Immunotherapy Based on the Cancer Stem Cell Antigens Properties.
    Mahmoodi S; Nezafat N; Negahdaripour M; Ghasemi Y
    Curr Mol Med; 2019; 19(1):2-11. PubMed ID: 30714514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem cell antigens as targets for new combined anti-cancer therapies.
    Quaglino E; Cavallo F; Conti L
    Int J Biochem Cell Biol; 2020 Dec; 129():105861. PubMed ID: 33031926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
    Safa AR
    Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses to human cancer stem-like cells/cancer-initiating cells.
    Hirohashi Y; Torigoe T; Tsukahara T; Kanaseki T; Kochin V; Sato N
    Cancer Sci; 2016 Jan; 107(1):12-7. PubMed ID: 26440127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunology of cancer stem cells in solid tumours. A review.
    Maccalli C; Volontè A; Cimminiello C; Parmiani G
    Eur J Cancer; 2014 Feb; 50(3):649-55. PubMed ID: 24333096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and opportunities for cancer stem cell-targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell-dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes.
    Alqarni A; Jasim SA; Altalbawy FMA; Kaur H; Kaur I; Rodriguez-Benites C; Deorari M; Alwaily ER; Al-Ani AM; Redhee AH
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23719. PubMed ID: 38764138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cells and ceramide signaling: the cutting edges of immunotherapy.
    Ghosh S; Juin SK; Majumdar S
    Mol Biol Rep; 2020 Oct; 47(10):8101-8111. PubMed ID: 32885363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concise Review: Targeting Cancer Stem Cells and Their Supporting Niche Using Oncolytic Viruses.
    Crupi MJF; Bell JC; Singaravelu R
    Stem Cells; 2019 Jun; 37(6):716-723. PubMed ID: 30875126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
    Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
    Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin β4-Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis.
    Ruan S; Lin M; Zhu Y; Lum L; Thakur A; Jin R; Shao W; Zhang Y; Hu Y; Huang S; Hurt EM; Chang AE; Wicha MS; Li Q
    Cancer Res; 2020 Feb; 80(4):771-783. PubMed ID: 31843981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.